Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Jade Biosciences, Inc.
High uncertainty: The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-32.1% vs price
Base Case (Median)
17.2% vs price
Bull Case (75th pct.)
66.5% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $2.79 | -81.3% | High (40%) |
| Graham Number | $32.16 | 115.7% | Medium (40%) |
Based on 2 out of 7 methods, JBIO appears fairly valued at the current price of $14.91. The base case fair value of $17.48 implies 17.2% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.